Dr Benjamin Daniels

Senior Research Fellow

PhD, Pharmacoepidemiology (University of New South Wales)
MA, Sociology & Statistics (McGill University)
BSc, Psychology (Drexel University)

Medicine & Health

School of Population Health

I am a nationally and internationally recognised leader in research leveraging linked administrative health data to investigate cancer treatment, outcomes, and national cancer policies. I am currently a Senior Research Fellow and��Cancer Institute NSW Early Career Fellow within the Medicines Intelligence Research Program (MedIntel) at the School of Population Health. My research focuses on biologic cancer therapies, multiple medicine use (polypharmacy), opioids, and the policies governing access to medicines. I apply population health science methods to inform clinical, policy, and patient decisions. I promote policy that supports the quality use of medicines and good practice in the access to and use of real-world data for research purposes.

Phone

9385 1412

E-mail

b.daniels@unsw.edu.au

Journal articles | 2024

Daniels B; Luckett T; Liauw W; Falster MO; Gisev N; Blyth FM; Pearson SA, 2024, 'Trajectories of Opioid Use Before and After Cancer Diagnosis: A Population-Based Cohort Study', Journal of Pain and Symptom Management, 68, pp. 282 - 291.e11,

Journal articles | 2024

Gillies MB; Bharat C; Camacho X; Daniels B; Hall K; Kelly TL; Kelty E; Lin J; Litchfield M; Lopez D; Noghrehchi F; Raubenheimer J; Varney B; Pratt N, 2024, 'Medicine utilization studies in Australian individual-level dispensing data: A blinded, multi-center replicated analysis', Pharmacoepidemiology and Drug Safety, 33,

Journal articles | 2024

Koch FC; Olivier J; Brett J; Buckley NA; Gisev N; Pearson S; Daniels B, 2024, 'The impact of tightened prescribing restrictions for PBS-subsidised opioid medicines and the introduction of half-pack sizes, Australia, 2020–21: an interrupted time series analysis', Medical Journal of Australia, 220, pp. 315 - 322,

Journal articles | 2024

Koch FC; Tang M; Walpola R; Aslam M; Pearson SA; Daniels B, 2024, 'Changes in systemic cancer therapy in Australia during the Delta and Omicron waves of the COVID-19 pandemic (2021–2022): a controlled interrupted time series analysis', Public Health Research and Practice, 34,

Journal articles | 2024

Lord SJ; Kiely BE; O'Connell DL; Daniels B; Beith J; Smith AL; Pearson SA; Chiew KL; Bulsara MK; Houssami N, 2024, 'Characteristics and post-metastasis survival of recurrent metastatic breast cancer over time – An Australian population-based record linkage study, 2001–2016', European Journal of Cancer, 197,

Journal articles | 2024

Zoega H; Falster M; Gillies M; Litchfield M; Camacho X; Bruno C; Daniels B; Donnolley N; Havard A; Schaffer A; Chambers G; Degenhardt L; Dobbins T; Gisev N; Ivers R; Jorm L; Liu B; Vajdic C; Pearson SA, 2024, 'The Medicines Intelligence Data Platform: A Population-Based Data Resource From New South Wales, Australia', Pharmacoepidemiology and Drug Safety, 33,

Journal articles | 2023

Chitty KM; Buckley NA; Lim J; Ali Z; Schumann JL; Cairns R; Daniels B; Pearson SA; Preen DB; Schaffer AL, 2023, 'Psychotropic and other medicine use at time of death by suicide: a population-level analysis of linked dispensing and forensic toxicology data', Medical Journal of Australia, 219, pp. 63 - 69,

Journal articles | 2023

Daniels B; Aslam M; van Leeuwen MT; Brown M; Hunt L; Gurney H; Tang M; Pearson SA; Vajdic CM, 2023, 'Prevalence of Australians exposed to potentially cardiotoxic cancer medicines: a population-based cohort study', The Lancet Regional Health - Western Pacific, 39, pp. 100872,

Journal articles | 2023

Daniels B; Tang M; Aslam M, 2023, 'Living with COVID-19 and cancer: the need for observational research in the post-pandemic world', The Lancet Regional Health - Western Pacific, 38,

Journal articles | 2023

Gisev N; Buizen L; Hopkins RE; Schaffer AL; Daniels B; Bharat C; Dobbins T; Larney S; Blyth F; Currow DC; Wilson A; Pearson SA; Degenhardt L, 2023, 'Five-Year Trajectories of Prescription Opioid Use', JAMA Network Open, 6, pp. E2328159,

Journal articles | 2023

Lopez D; Strange C; Sanfilippo F; Daniels B; Pearson S; Preen D, 2023, 'Priorities for building Australian workforce capacity to leverage population-based, routinely collected data: views from pharmacoepidemiology', Public Health Research and Practice, 33,

Journal articles | 2023

Tang M; Daniels B; Coory M; Pearson SA, 2023, 'Timely and comprehensive real-world data for optimizing lung cancer treatment and outcomes for Australians', Asia-Pacific Journal of Clinical Oncology, 19, pp. 413 - 414,

Journal articles | 2022

Daniels B; Havard A; Myton R; Lee C; Chidwick K, 2022, 'Evaluating the accuracy of data extracted from electronic health records into MedicineInsight, a national Australian general practice database', International Journal of Population Data Science, 7,

Journal articles | 2022

Daniels B; Schaffer A; Buckley NA; Bruno C; Jun M; Pearson SA; Zoega H, 2022, 'The impact of tightened prescribing restrictions on proton pump inhibitor use in Australia: An evaluation using interrupted time series analysis', Pharmacoepidemiology and Drug Safety, 31, pp. 370 - 378,

Journal articles | 2022

Hong S; Daniels B; van Leeuwen MT; Pearson SA; Vajdic CM, 2022, 'Incidence and risk factors of hypertension therapy in Australian cancer patients treated with vascular signalling pathway inhibitors', Discover Oncology, 13, pp. 6,

Journal articles | 2022

Liu D; Gunther K; Enriquez LA; Daniels B; O’Mara TA; Tang K; Spurdle AB; Ford CE, 2022, 'Author Correction: ROR1 is upregulated in endometrial cancer and represents a novel therapeutic target (Scientific Reports, (2020), 10, 1, (13906), 10.1038/s41598-020-70924-z)', Scientific Reports, 12,

Journal articles | 2022

Lord SJ; Bahlmann K; O'Connell DL; Kiely BE; Daniels B; Pearson SA; Beith J; Bulsara MK; Houssami N, 2022, 'De novo and recurrent metastatic breast cancer – A systematic review of population-level changes in survival since 1995', eClinicalMedicine, 44,

Journal articles | 2022

Lord SJ; Daniels B; Kiely BE; O'Connell DL; Beith J; Pearson S; Chiew KL; Bulsara MK; Houssami N, 2022, 'Long term risk of distant metastasis in women with non-metastatic breast cancer and survival after metastasis detection: a population-based linked health records study', Medical Journal of Australia, 217, pp. 402 - 409,

Journal articles | 2022

Daniels B; Havard A; Myton R; Lee C; Chidwick K, 2022, 'Evaluating the accuracy of data extracted from electronic health records into MedicineInsight, a national Australian general practice database', INTERNATIONAL JOURNAL OF POPULATION DATA SCIENCE (IJPDS), vol. 7,

Journal articles | 2021

Brett J; Pearson SA; Daniels B; Wylie CE; Buckley NA, 2021, 'A cross sectional study of psychotropic medicine use in Australia in 2018: A focus on polypharmacy', British Journal of Clinical Pharmacology, 87, pp. 1369 - 1377,

Journal articles | 2021

Busingye D; Daniels B; Brett J; Pollack A; Belcher J; Chidwick K; Blogg S, 2021, 'Patterns of real-world opioid prescribing in Australian general practice (2013-18)', Australian Journal of Primary Health, 27, pp. 416 - 424,

Journal articles | 2021

Daniels B; Healey P; Bruno C; Kaan I; Zoega H, 2021, 'Medicine treatment of glaucoma in Australia 2012-2019: Prevalence, incidence and persistence', BMJ Open Ophthalmology, 6, pp. e000921,

Journal articles | 2021

Daniels B; Kiely BE; Tang M; Houssami N; Lord SJ; Pearson SA, 2021, 'Trastuzumab emtansine for HER2-positive metastatic breast cancer: Outcomes from a whole-of-population Australian cohort', Breast, 58, pp. 106 - 112,

Journal articles | 2021

Daniels B; Luckett T; Holliday S; Liauw W; Lovell M; Phillips J; Rowett D; John TN; Tervonen H; Pearson SA, 2021, 'Patterns of oxycodone controlled release use in older people with cancer following public subsidy of oxycodone/naloxone formulations: An Australian population-based study', Asia-Pacific Journal of Clinical Oncology, 17, pp. 68 - 78,

Journal articles | 2021

Daniels B; Pearson SA; Buckley NA; Bruno C; Schaffer A; Zoega H, 2021, 'Coming to grips with seemingly conflicting results in programme evaluation: The devil's in the detail', BMJ Quality and Safety, 30, pp. 70 - 71,

Journal articles | 2021

Falster MO; Charrier R; Pearson SA; Buckley NA; Daniels B, 2021, 'Long-term trajectories of medicine use among older adults experiencing polypharmacy in Australia', British Journal of Clinical Pharmacology, 87, pp. 1264 - 1274,

Journal articles | 2021

Havard A; Manski-Nankervis JA; Thistlethwaite J; Daniels B; Myton R; Tu K; Chidwick K, 2021, 'Validity of algorithms for identifying five chronic conditions in MedicineInsight, an Australian national general practice database', BMC Health Services Research, 21, pp. 551,

Journal articles | 2021

Hong S; Daniels B; Leeuwen MT; Pearson S-A; Vajdic CM, 2021, 'Incidence And Risk Factors of Hypertension Therapy In Australian Cancer Patients Treated With Vascular Signalling Pathway Inhibitors', ,

Journal articles | 2021

Tadrous M; Daniels B; Pearson SA; Gomes T, 2021, 'Comparison of claims from high-drug cost beneficiaries in Ontario, Canada, and Australia: a cross-sectional analysis', CMAJ open, 9, pp. E1048 - E1054,

Journal articles | 2021

Tang M; Daniels B; Aslam M; Schaffer A; Pearson SA, 2021, 'Changes in systemic cancer therapy in Australia during the COVID-19 pandemic: a population-based study', The Lancet Regional Health - Western Pacific, 14, pp. 100226,

Journal articles | 2021

Tang M; Daniels B; Schaffer AL; Pearson SA, 2021, 'Real-world data to advance HER2-targeted cancer medicines research: Playing to the strengths of clinical registry and administrative data', Asia-Pacific Journal of Clinical Oncology, 17, pp. 414 - 415,

Journal articles | 2021

Tang M; Schaffer AL; Kiely BE; Daniels B; Lee CK; Simes RJ; Pearson SA, 2021, 'Cardiac assessment in Australian patients receiving (neo)adjuvant trastuzumab for HER2-positive early breast cancer: a population-based study', Breast Cancer Research and Treatment, 187, pp. 893 - 902,

Journal articles | 2020

Bruno C; Pearson SA; Daniels B; Buckley NA; Schaffer A; Zoega H, 2020, 'Passing the acid test? Evaluating the impact of national education initiatives to reduce proton pump inhibitor use in Australia', BMJ Quality and Safety, 29, pp. 365 - 373,

Journal articles | 2020

Coleman L; Brett J; Daniels B; Pearson S; Falster M, 2020, 'Medicine reviews: do they reduce benzodiazepine use in older Australians?', Public Health Research & Practice, 31,

Journal articles | 2020

Daniels B; Pearson SA; Buckley NA; Bruno C; Zoega H, 2020, 'Long-term use of proton-pump inhibitors: whole-of-population patterns in Australia 2013–2016', Therapeutic Advances in Gastroenterology, 13,

Journal articles | 2020

Daniels B; Pearson SA; Vajdic CM; Pottegård A; Buckley NA; Zoega H, 2020, 'Risk of squamous cell carcinoma of the lip and cutaneous melanoma in older Australians using hydrochlorothiazide: A population-based case-control study', Basic and Clinical Pharmacology and Toxicology, 127, pp. 320 - 328,

Journal articles | 2020

Daniels B; Tervonen HE; Pearson SA, 2020, 'Identifying incident cancer cases in dispensing claims: A validation study using Australia's Repatriation Pharmaceutical Benefits Scheme (PBS) data', International Journal of Population Data Science, 5,

Journal articles | 2020

Favell DL; Tang M; Daniels B; Vajdic CM; Zoega H; Pearson SA, 2020, 'Capture of systemic anticancer medicines in pharmaceutical benefits scheme (PBS) data likely higher than previously reported', Public Health Research and Practice, 30,

Journal articles | 2020

Homaira N; Daniels B; Pearson S; Jaffe A, 2020, 'Dispensing practices of fixed dose combination controller therapy for asthma in australian children and adolescents', International Journal of Environmental Research and Public Health, 17, pp. 1 - 7,

Journal articles | 2020

Liu D; Gunther K; Enriquez LA; Daniels B; O’Mara TA; Tang K; Spurdle AB; Ford CE, 2020, 'ROR1 is upregulated in endometrial cancer and represents a novel therapeutic target', Scientific Reports, 10,

Journal articles | 2020

Tang M; Schaffer A; Kiely BE; Daniels B; Simes RJ; Lee CK; Pearson SA, 2020, 'Correction: Treatment patterns and survival in HER2-positive early breast cancer: a whole-of-population Australian cohort study (2007–2016) (British Journal of Cancer, (2019), 121, 11, (904-911), 10.1038/s41416-019-0612-5)', British Journal of Cancer, 123, pp. 868,

Journal articles | 2020

Wu J; Dickinson S; Elgebaly Z; Blogg S; Heaney A; Soo Y; Daniels B; Weekes L, 2020, 'Impact of NPS MedicineWise general practitioner education programs and Choosing Wisely Australia recommendations on prescribing of proton pump inhibitors in Australia', BMC Family Practice, 21, pp. 85,

Journal articles | 2020

Wylie CE; Daniels B; Brett J; Pearson SA; Buckley NA, 2020, 'A national study on prescribed medicine use in Australia on a typical day', Pharmacoepidemiology and Drug Safety, 29, pp. 1046 - 1053,

Journal articles | 2020

Zheng D; Brett J; Daniels B; Buckley NA; Pearson SA; Schaffer AL, 2020, 'Potentially inappropriate benzodiazepine use in Australian adults: A population-based study (2014–2017)', Drug and Alcohol Review, 39, pp. 575 - 582,

Journal articles | 2019

Daniels B; Kiely BE; Tang M; Tervonen H; Pearson SA, 2019, 'Trastuzumab use in older patients with HER2-positive metastatic breast cancer: Outcomes and treatment patterns in a whole-of-population Australian cohort (2003-2015)', BMC Cancer, 19, pp. 909,

Journal articles | 2019

Lord SJ; Kiely BE; Pearson SA; Daniels B; O'Connell DL; Beith J; Bulsara MK; Houssami N, 2019, 'Metastatic breast cancer incidence, site and survival in Australia, 2001-2016: A population-based health record linkage study protocol', BMJ Open, 9,

Journal articles | 2019

Tang M; Schaffer A; Kiely BE; Daniels B; Simes RJ; Lee CK; Pearson SA, 2019, 'Treatment patterns and survival in HER2-positive early breast cancer: a whole-of-population Australian cohort study (2007–2016)', British Journal of Cancer, 121, pp. 904 - 911,

Journal articles | 2019

Tervonen HE; Daniels B; Tang M; Preen DB; Pearson SA, 2019, 'Patterns of endocrine therapy in a national cohort of early stage HER2-positive breast cancer patients', Pharmacoepidemiology and Drug Safety, 28, pp. 812 - 820,

Journal articles | 2018

Brett J; Zoega H; Buckley NA; Daniels BJ; Elshaug AG; Pearson SA, 2018, 'Choosing wisely? Quantifying the extent of three low value psychotropic prescribing practices in Australia', BMC Health Services Research, 18, pp. 1009,

Journal articles | 2018

Daniels B; Girosi F; Tervonen H; Kiely BE; Lord SJ; Houssami N; Pearson SA, 2018, 'Adherence to prescribing restrictions for her2-positive metastatic breast cancer in Australia: A national population-based observational study (2001-2016)', PLoS ONE, 13,

Journal articles | 2018

Daniels B; Kiely BE; Houssami N; Lord SJ; Dobbins T; Lu CY; Ward RL; Pearson SA, 2018, 'Survival outcomes for Australian women receiving trastuzumab for HER2-positive metastatic breast cancer following (neo)adjuvant trastuzumab: A national population-based observational study (2006-2014)', British Journal of Cancer, 118, pp. 441 - 447,

Journal articles | 2018

Daniels B; Kiely BE; Lord SJ; Houssami N; Lu CY; Ward RL; Pearson SA, 2018, 'Long-term survival in trastuzumab-treated patients with HER2-positive metastatic breast cancer: real-world outcomes and treatment patterns in a whole-of-population Australian cohort (2001–2016)', Breast Cancer Research and Treatment, 171, pp. 151 - 159,

Journal articles | 2018

Daniels B; Kiely BE; Lord SJ; Houssami N; Lu CY; Ward RL; Pearson SA, 2018, 'Trastuzumab for metastatic breast cancer: Real world outcomes from an Australian whole-of-population cohort (2001–2016)', Breast, 38, pp. 7 - 13,

Journal articles | 2018

Henry CE; Llamosas E; Daniels B; Coopes A; Tang K; Ford CE, 2018, 'ROR1 and ROR2 play distinct and opposing roles in endometrial cancer', Gynecologic Oncology, 148, pp. 576 - 584,

Journal articles | 2018

Lopez D; Daniels B; Sanfilippo F; Pearson S; Martini A; Preen DB, 2018, 'Needs and priority areas for building capacity for working with linked data in the Australian pharmacoepidemiology workforce', International Journal of Population Data Science, 3,

Journal articles | 2018

Tan SYS; O’Neill S; Goldstein D; Ward RL; Daniels B; Vajdic CM, 2018, 'Predictors of care for patients with cancer of unknown primary site in three Australian hospitals', Asia-Pacific Journal of Clinical Oncology, 14, pp. e512 - e520,

Journal articles | 2017

Brett J; Daniels B; Karanges EA; Buckley NA; Schneider C; Nassir A; McLachlan AJ; Pearson SA, 2017, 'Psychotropic polypharmacy in Australia, 2006 to 2015: a descriptive cohort study', British Journal of Clinical Pharmacology, 83, pp. 2581 - 2588,

Journal articles | 2017

Brett J; Karanges EA; Daniels B; Buckley NA; Schneider C; Nassir A; Zoega H; McLachlan AJ; Pearson SA, 2017, 'Psychotropic medication use in Australia, 2007 to 2015: Changes in annual incidence, prevalence and treatment exposure', Australian and New Zealand Journal of Psychiatry, 51, pp. 990 - 999,

Journal articles | 2017

Daniels B; Lord SJ; Kiely BE; Houssami N; Haywood P; Lu CY; Ward RL; Pearson SA, 2017, 'Use and outcomes of targeted therapies in early and metastatic HER2-positive breast cancer in Australia: Protocol detailing observations in a whole of population cohort', BMJ Open, 7,

Journal articles | 2017

Harris CA; Daniels BJ; Ward RL; Pearson SA, 2017, 'Retrospective comparison of Australia’s Pharmaceutical Benefits Scheme claims data with prescription data in HER2 positive early breast cancer patients (2008-2012)', Public Health Research and Practice, 27,

Journal articles | 2017

Ma SSQ; Henry CE; Llamosas E; Higgins R; Daniels B; Hesson LB; Hawkins NJ; Ward RL; Ford CE, 2017, 'Validation of specificity of antibodies for immunohistochemistry: the case of ROR2', Virchows Archiv : an international journal of pathology, 470, pp. 99 - 108,

Journal articles | 2016

Cairns R; Daniels B; Wood DA; Brett J, 2016, 'ADHD medication overdose and misuse: The NSW poisons information centre experience, 2004-2014', Medical Journal of Australia, 204, pp. 154.e1 - 154.e7,

Journal articles | 2016

Cairns R; Daniels B; Wood DA; Brett J, 2016, 'ADHD medication overdose and misuse: the NSW Poisons Information Centre experience, 2004-2014', The Medical journal of Australia, 204, pp. 154

Journal articles | 2016

Ma SSQ; Henry CE; Llamosas E; Higgins R; Daniels B; Hesson LB; Hawkins NJ; Ward RL; Ford CE, 2016, 'Erratum to: Validation of specificity of antibodies for immunohistochemistry: the case of ROR2 (Virchows Archiv, (2016), 10.1007/s00428-016-2019-5)', Virchows Archiv, 469, pp. 717,

Journal articles | 2016

Vajdic CM; Mayson E; Dodds AJ; O'Brien T; Wilcox L; Nivison-Smith I; Le Marsney R; Daniels B; Ashton LJ; Tan J; Bilmon I; Aarons D; Tran S; Gibson J; Johnston A; Greenwood M; Forbes M; Hertzberg M; Huang G; Spencer A; Muirhead J; Szer J; Mason K; Lewis I; To C; Durrant S; Western R; Cannell P; Buffery S; Oswald C; Nelson A; Shaw P; Pearson L; Tiedemann K; Scoyne M; Fraser C; Seljak J; Cole C; Rowland K; Gough H; Tapp H; Green N; Moa A; McRae J; Jenkins M; Hicks J; Chaplin K, 2016, 'Second Cancer Risk and Late Mortality in Adult Australians Receiving Allogeneic Hematopoietic Stem Cell Transplantation: A Population-Based Cohort Study', Biology of Blood and Marrow Transplantation, 22, pp. 949 - 956,

Journal articles | 2015

Blanch B; Daniels B; Litchfield M; Pearson SA, 2015, 'Looking forward and looking back: The balancing act in new drug user designs for pharmacoepidemiological research', Pharmacoepidemiology and Drug Safety, 24, pp. 1117 - 1119,

Journal articles | 2015

Henry C; Quadir A; Hawkins NJ; Jary E; Llamosas E; Kumar D; Daniels B; Ward RL; Ford CE, 2015, 'Expression of the novel Wnt receptor ROR2 is increased in breast cancer and may regulate both β-catenin dependent and independent Wnt signalling', Journal of Cancer Research and Clinical Oncology, 141, pp. 243 - 254,

Journal articles | 2015

Mellish L; Karanges EA; Litchfield MJ; Schaffer AL; Blanch B; Daniels BJ; Segrave A; Pearson SA, 2015, 'The Australian Pharmaceutical Benefits Scheme data collection: A practical guide for researchers', BMC Research Notes, 8, pp. 634,

Journal articles | 2015

Nelson AS; Ashton LJ; Vajdic CM; Le Marsney RE; Daniels B; Nivison-Smith I; Wilcox L; Dodds AJ; O'Brien TA; Moa A, 2015, 'Second cancers and late mortality in Australian children treated by allogeneic HSCT for haematological malignancy', Leukemia, 29, pp. 441 - 447,

Journal articles | 2015

Ward RL; Laaksonen MA; van Gool K; Pearson SA; Daniels B; Bastick P; Norman R; Hou C; Haywood P; Haas M, 2015, 'Cost of cancer care for patients undergoing chemotherapy: The elements of cancer care study', Asia-Pacific Journal of Clinical Oncology, 11, pp. 178 - 186,

Journal articles | 2014

Bilmon IA; Ashton LJ; Le Marsney RE; Dodds AJ; O'brien TA; Wilcox L; Nivison-Smith I; Daniels B; Vajdic CM; Dodds A; Tan J; Aarons D; Tran S; Gibson J; Johnston A; Greenwood M; Forbes M; Hertzberg M; Huang G; Spencer A; Muirhead J; Szer J; Mason K; Lewis I; To C; Durrant S; Western R; Cannell P; Buffery S; Oswald C; Nelson A; Shaw P; Pearson L; Tiedemann K; Scoyne M; Fraser C; Seljak J; Cole C; Rowland K; Gough H; Tapp H; Green N; Moa A; McRae J; Jenkins M; Hicks J; Chaplin K, 2014, 'Second cancer risk in adults receiving autologous haematopoietic SCT for cancer: A population-based cohort study', Bone Marrow Transplantation, 49, pp. 691 - 698,

Journal articles | 2014

Couttas TA; Kain N; Daniels B; Lim XY; Shepherd C; Kril J; Pickford R; Li H; Garner B; Don AS, 2014, 'Loss of the neuroprotective factor Sphingosine 1-phosphate early in Alzheimer's disease pathogenesis', Acta Neuropathologica Communications, 2,

Journal articles | 2013

Abuhusain HJ; Matin A; Qiao Q; Shen H; Kain N; Day BW; Stringer BW; Daniels B; Laaksonen MA; Teo C; McDonald KL; Don AS, 2013, 'A metabolic shift favoring sphingosine 1-phosphate at the expense of ceramide controls glioblastoma angiogenesis', Journal of Biological Chemistry, 288, pp. 37355 - 37364,
Preprints | 2024

Zoega H; Falster M; Gillies M; Litchfield M; Camacho X; Bruno C; Daniels B; Donnolley N; Havard A; Schaffer A; Chambers G; Degenhardt L; Dobbins T; Gisev N; Ivers R; Jorm L; Liu B; Vajdic C; Pearson S-A, 2024, The Medicines Intelligence Data Platform: A population-based data resource from New South Wales, Australia,

Conference Abstracts | 2022

Chitty K; Buckley N; Lim J; Ali Z; Schumann J; Cairns R; Daniels B; Preen D; Schaffer A, 2022, 'An overview of psychotropic pharmacotherapy at time of death by suicide: An Australian-wide case series study using administrative and coronial data', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 31, pp. 71 - 72,

Conference Abstracts | 2022

Daniels B; Luckett T; Falster MO; Liauw W; Gisev N; Pearson S-A, 2022, 'Understanding opioid use prior to and immediately following cancer diagnosis using group-based trajectory models (GBTM)', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 31, pp. 525 - 526,

Conference Papers | 2022

Franchini F; Trapani K; Gillett P; Degeling K; Daniels B; Pearson S; Yang O; Zhang Y; Gibbs P; Ben S; McArthur G; Desai J; Fox S; IJzerman M, 2022, 'The PRIMCAT cohort study: Analysis of treatment utilisation, costs, and outcomes in Victoria for patients with cancer', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 180 - 181,

Conference Papers | 2022

Gisev N; Buizen L; Schaffer A; Daniels B; Pearson S-A; Dobbins T; Blyth F; Larney S; Currow DC; Wilson A; Degenhardt L, 2022, '| New South Wales, Long-term trajectories of prescription opioid use in New South Wales, Australia', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, pp. 371 - 372,

Conference Papers | 2022

Koch FC; Olivier J; Pearson S-A; Daniels B, 2022, 'A multivariate interrupted time series analysis assessing the impacts of half-pack sizes and increased access restrictions on publicly subsidized opioids in Australia', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, pp. 541 - 542,

Conference Abstracts | 2021

Daniels B; Pearson S-A; Bruno C; Buckley N; Schaffer A; Jun M; Zoega H, 2021, 'Evaluating the impact of new prescribing restrictions for publicy-subsidised proton pump inhibitors in Australia: An interrupted time series analysis', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 30, pp. 219 - 220,

Conference Papers | 2021

Havard A; Chidwick K; Daniels B; Thistlethwaite J; Myton R; Blogg S; Wall M; Quick L; Pollack A; Manski-Nankervis J-A, 2021, 'Validity of algorithms for identifying five chronic conditions in MedicineInsight, Australian national primary care data', in INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, OXFORD UNIV PRESS,

Conference Papers | 2021

Liu D; Enriquez L; Daniels B; O'Mara T; Tang K; Ford C, 2021, 'Abstract PO042: ROR2 is epigenetically regulated in endometrial cancer', in Clinical Cancer Research, American Association for Cancer Research (AACR), pp. PO042 - PO042,

Conference Papers | 2021

Lord S; Daniels B; Kiely B; O'Connell D; Pearson S-A; Beith J; Bulsara M; Houssami N, 2021, 'Long-term risk of distant metastasis and post-metastasis survival for breast cancer: health record linkage study', in INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, OXFORD UNIV PRESS,

Conference Papers | 2021

Tang M; Daniels B; Aslam M; Schaffer AL; Pearson S-A, 2021, 'Changes in systemic cancer therapy in Australia during the COVID-19 pandemic: a population-based study', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 69 - 70,

Conference Papers | 2021

Tang M; Schaffer A; Kiely B; Daniels B; Lee C; Simes J; Pearson S-A, 2021, 'Cardiac assessment in Australian patients receiving trastuzumab for HER2+early breast cancer', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 30 - 30,

Conference Abstracts | 2020

Daniels B; Pearson S-A; Vajdic CM; Pottegard A; Buckley NA; Buckley NA; Zoega H, 2020, 'Risks of squamous cell carcinoma of the lip and cutaneous melanoma in older Australians using hydrochlorothiazide (HCTZ)', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 29, pp. 37 - 38,

Conference Abstracts | 2020

Falster MO; Charrier R; Pearson S; Buckley N; Daniels B, 2020, 'Long-term trajectories of medicine use among older adults experiencing polypharmacy in Australia', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Virtual, Vol. 29, pp. 199 - 199, presented at 36th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Virtual, 16 September 2020,

Conference Abstracts | 2020

Liu D; Enriquez L; Daniels B; O'Mara T; Tang K; Ford C, 2020, 'ROR2 is epigenetically regulated in endometrial cancer', in CLINICAL CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, ELECTR NETWORK, Vol. 27, presented at AACR Special Conference on Endometrial Cancer - New Biology Driving Research and Treatment, ELECTR NETWORK, 09 November 2020 - 10 November 2020,

Conference Abstracts | 2020

Liu D; Gunther K; Daniels B; O'Mara T; Tang K; Ford C, 2020, 'ROR1: A novel target in endometrial cancer', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, ELECTR NETWORK, Vol. 80, presented at AACR Annual Meeting, ELECTR NETWORK, 22 June 2020 - 24 June 2020,

Conference Abstracts | 2019

Bruno C; Pearson S-A; Daniels B; Buckley N; Zoega H, 2019, 'Proton pump inhibitor (PPI) use in Australia: Evaluating national quality use of medicines initiatives', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 28, pp. 519 - 519,

Conference Abstracts | 2019

Daniels B; Wylie C; Pearson S-A; Brett J; Buckley N, 2019, 'A day in the life: Prescription medicine use in Australia', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 28, pp. 545 - 545,

Conference Presentations | 2019

Daniels B, 2019, 'A Day in the Life: Prescription Medicine Use in Australia', presented at International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Philadelphia, PA, USA, 26 August 2019 - 28 August 2019

Conference Presentations | 2019

Daniels B, 2019, 'Identifying incident cancer cases in medicine dispensing claims: A validation study using Australia’s Pharmaceutical Benefits Scheme (PBS) data', presented at Asian Conference on Pharmacoepidemiology & Therapeutic Risk Management, 11 October 2019 - 13 October 2019

Conference Presentations | 2019

Daniels B, 2019, 'Understanding Treatment Pathways for HER2-Positive Metastatic Breast Cancer (HER2+MBC) Patients: Analysis Using Group-Based Trajectory Models (GBTM)', presented at International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Prague, Czechia, 24 August 2019 - 26 August 2019

Conference Presentations | 2019

Daniels B, 2019, 'Validating administrative health data in Australia', presented at Asian Conference on Pharmacoepidemiology, Kyoto, Japan, 11 October 2019 - 13 October 2019

Preprints | 2018

Daniels B; Girosi F; Tervonen H; Kiely BE; Lord SJ; Houssami N; Pearson S-A, 2018, Adherence to prescribing restrictions for HER2-positive metastatic breast cancer in Australia: a national population-based observational study (2001-2016),

Conference Papers | 2018

Daniels B; Kiely BE; Lord SJ; Houssami N; Pearson S-A, 2018, 'Abstract P2-12-01: Real-world use and outcomes of trastuzumab for HER2+ metastatic breast cancer in Australia: Analysis of the herceptin program, 2001-2015', in Cancer Research, American Association for Cancer Research (AACR), presented at Abstracts: 2017 San Antonio Breast Cancer Symposium; December 5-9, 2017; San Antonio, Texas,

Conference Abstracts | 2018

Homaira N; Daniels B; Pearson S; Jaffe A, 2018, 'PATTERNS OF PRESCRIBED ASTHMA MEDICINE USE IN AUSTRALIAN CHILDREN: A POPULATION-BASED STUDY', in RESPIROLOGY, WILEY, Vol. 23, pp. 107 - 107,

Conference Presentations | 2017

Daniels B, 2017, 'Did a policy to ease the prescribing restrictions for lapatinib as second-line HER2-positive metastatic breast cancer increase initiation rates?', presented at International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Montreal, QC, Canada, 26 August 2017 - 28 August 2018

Conference Presentations | 2017

Daniels B, 2017, 'Patterns of care and outcomes for long-term survivors with HER2-positive metastatic breast cancer (HER2+MBC) starting trastuzumab: An Australian whole-of-population cohort study', presented at Clinical Oncology Society of Australia Annual Scientific Meeting, 13 November 2017 - 15 November 2017

Conference Presentations | 2017

Daniels B, 2017, 'Patterns of care for long-term surviving trastuzumab-treated patients with HER2-positive metastatic breast cancer (HER2+MBC): an Australian whole-of-population cohort study', presented at Asian Conference on Pharmacoepidemiology & Therapeutic Risk Management., 30 October 2017 - 01 November 2017

Conference Presentations | 2017

Daniels B, 2017, 'Real-world use and outcomes of trastuzumab for HER2+ metastatic breast cancer in Australia: Analysis of the Herceptin Program, 2001 – 2015', presented at San Antonio Breast Cancer Symposium, San Antonio, TX, USA, 06 December 2017 - 10 December 2017

Conference Presentations | 2016

Daniels B, 2016, 'Opportunities for post-market surveillance of high cost medicines in Australia: Observing trastuzumab-treated women from early- through late-stage HER2-positive breast cancer (HER2+BC)', presented at International Population Data Linkage Conference, Swansea, Wales, UK, 23 August 2016 - 26 August 2016

Conference Presentations | 2016

Daniels B, 2016, 'Real-word use and outcomes of trastuzumab for metastatic breast cancer in Australia: Analysis of the Herceptin Program, 2001 – 2014', presented at Clinical Oncology Society of Australia Annual Scientific Meeting, Gold Coast, QLD, 15 November 2016 - 17 November 2016

Conference Presentations | 2016

Daniels B, 2016, 'Tracking trastuzumab (H) therapy in early- through late-stage HER2-positive breast cancer (HER2+BC) in Australia: A national, retrospective cohort study', presented at International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Dublin, Ireland, 26 August 2016 - 29 August 2016

Conference Presentations | 2015

Daniels B, 2015, 'Relative misclassification (RM) of new medicine users based on look-back period', presented at Australian Population Health Congress, 07 September 2015 - 09 September 2015

Conference Papers | 2014

Harris C; Daniels B; Ward R; Pearson S-A, 2014, 'Do Pharmaceutical Claims Accurately Reflect Oncology Prescribing Practice: Evidence from an Australian HER2+Early Breast Cancer Cohort (HER2EBC)', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY-BLACKWELL, pp. 465 - 466,

Conference Papers | 2014

Harris C; Pearson S-A; Daniels B; Ward R, 2014, 'HER2 Positive Early Breast Cancer (HER2EBC): An Australian Patterns of Care Study', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY-BLACKWELL, pp. 468 - 468,

Conference Presentations | 2014

Peng J; Liu JJ; Daniels B; Firriolo J; Laaksonen MA; Hawkins NJ; Meagher AP; Hayes I; Croxford M; Cai S; Ward RL, 2014, 'RETROSPECTIVE COMPARISON OF RECTAL CANCER TREATMENT IN CHINA AND AUSTRALIA FROM 1995-2012',

Conference Abstracts | 2013

Abuhusain H; Matin A; Qiao Q; Shen H; Daniels B; Laaksonen M; Teo C; Don A; McDonald K, 2013, 'S1P: AN ALTERNATIVE ANTI-ANGIOGENIC TARGET IN GBM', in NEURO-ONCOLOGY, OXFORD UNIV PRESS INC, CA, San Francisco, Vol. 15, pp. 1 - 1, presented at 4th Quadrennial Meeting of the World-Federation-of-Neuro-Oncology (WFNO) held in conjunction with the 18th Annual Meeting of the Society-for-Neuro-Oncology (SNO), CA, San Francisco, 21 November 2013 - 24 November 2013,

Conference Presentations | 2013

Harris C; Daniels B; Ward R; Pearson S-A, 2013, 'DO PHARMACEUTICAL CLAIMS ACCURATELY REFLECT ONCOLOGY PRESCRIBING PRACTICE: EVIDENCE FROM AN AUSTRALIAN HER2+EARLY BREAST CANCER COHORT (HER2EBC)', Vol. 9, pp. 123 - 123,

Conference Presentations | 2013

Harris C; Pearson S-A; Daniels B; Srasuebkul P; Ward R, 2013, 'HER2 POSITIVE EARLY BREAST CANCER (HER2EBC): AN AUSTRALIAN PATTERN OF CARE STUDY', Vol. 9, pp. 81 - 81,

Conference Papers | 2013

Harris CA; Pearson S; Daniels B; Srasuebkul P; Ward RL, 2013, 'HER2-positive early breast cancer (HER2EBC): An Australian pattern of care study', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, CA, San Diego, presented at ASCO's Quality Care Symposium, CA, San Diego, 01 November 2013 - 02 November 2013,

Conference Papers | 2013

Harris CA; Ward RL; Daniels B; Pearson S, 2013, 'Do pharmaceutical claims accurately reflect oncology prescribing practice? Evidence from an Australian HER2+early breast cancer cohort ( HER2EBC).', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, CA, San Diego, presented at ASCO's Quality Care Symposium, CA, San Diego, 01 November 2013 - 02 November 2013,

Conference Presentations | 2012

Daniels B, 2012, 'Building chemotherapy protocols: linking dispensing and administration records from the Elements of Cancer Care study', presented at Australian Population Health Congress, Adelaide, SA, 10 September 2012 - 12 September 2012

UNSW Cancer Seed Grant (2023; $50,000), "Harnessing big data to improve access to care and outcomes in refugees and recent migrants diagnosed with cancer��" (Associate Investigator)
Cancer Institute NSW Early Career Fellowship (2022 - 2025; $345,000), "Leveraging big data for real-world evidence generation: Impact of multi-medicine use on bowel cancer treatment and survivorship outcomes"��
UNSW Cancer Seed Grant (2022; $50,000), "Understanding the impact of SARS-CoV-2 (COVID-19) on Australian cancer treatment"
NHMRC Ideas Grant,��"Disentangling the interrelationship between multimordibity, multimedicine use, and cardiovascular health" (Associate Investigator)��(2021 - 2023; $480,000)
NHMRC Post-graduate scholarship (2015-2018; $84,000)��

2020 - UNSW Medicine Early Career Academic Network (ECAN) Best Paper Award -��Public Health��

My Research Supervision

Jun Ni Ho (PhD candidate) - 'Optimisation of Risk Management for Biologic Medicines in Australia'

��

��������Ƶ

Follow

Dr Benjamin Daniels

Follow me

��Ƶ